A More Specific Anticoagulation Regimen Is Required for Patients After the Cox-Maze Procedure Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D. Holmes, PhD The Annals of Thoracic Surgery Volume 98, Issue 4, Pages 1331-1338 (October 2014) DOI: 10.1016/j.athoracsur.2014.05.088 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Kaplan-Meier survival curves demonstrating the time to oral anticoagulation (OAC) therapy discontinuation by CHADS2 score groups along with survival curves demonstrating low freedom from stroke/TIA events by CHADS2 score groups. The Annals of Thoracic Surgery 2014 98, 1331-1338DOI: (10.1016/j.athoracsur.2014.05.088) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Kaplan-Meier survival curves indicating time to oral anticoagulation (OAC) therapy discontinuation by CHADS2 score groups in (A) patients with nonstable sinus rhythm during follow-up (log rank, 0.26; p = 0.609) and (B) patients in stable sinus rhythm during follow-up (log rank = 16.81; p < 0.001). The Annals of Thoracic Surgery 2014 98, 1331-1338DOI: (10.1016/j.athoracsur.2014.05.088) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier survival curves demonstrating freedom from major bleeding events by CHADS2 score groups. The Annals of Thoracic Surgery 2014 98, 1331-1338DOI: (10.1016/j.athoracsur.2014.05.088) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions